An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)

Objective: The primary objective of this study is to estimate the prevalence of chronic kidney disease (CKD) among type 2 diabetes mellitus (T2DM) patients in India. Materials and Methods: This cross-sectional, observational, epidemiological, multi-center, study is enrolling T2DM patients of either...

Full description

Bibliographic Details
Main Authors: M Prasannakumar, Rajesh Rajput, Krishna Seshadri, Pradeep Talwalkar, Pankaj Agarwal, G Gokulnath, Bhavesh Kotak, Ammar Raza, Hardik Vasnawala, Chirag Teli
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=4;spage=520;epage=523;aulast=Prasannakumar
id doaj-0899a924cfb5449badab79405c68c450
record_format Article
spelling doaj-0899a924cfb5449badab79405c68c4502020-11-24T21:03:45ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002015-01-0119452052310.4103/2230-8210.157857An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)M PrasannakumarRajesh RajputKrishna SeshadriPradeep TalwalkarPankaj AgarwalG GokulnathBhavesh KotakAmmar RazaHardik VasnawalaChirag TeliObjective: The primary objective of this study is to estimate the prevalence of chronic kidney disease (CKD) among type 2 diabetes mellitus (T2DM) patients in India. Materials and Methods: This cross-sectional, observational, epidemiological, multi-center, study is enrolling T2DM patients of either gender aged 30 years or above. This study aimed to enroll a total of 3000 T2DM patients at 30 participating hospitals/clinics across India and the data from a planned interim analysis of 1500 patients are presented here. The primary endpoint of the study is to estimate proportion of T2DM patients with CKD (glomerular filtration rate [GFR] <60 ml/min/1.73 m 2 or albumin creatinine ratio [ACR] ≥30 mg/g or ≥3 mg/mmol or both). Routine treatment, as administered by the treating physician, was continued without any study specific intervention. Patients′ data pertaining to demographic characteristics, medical history, current medication and physical examination were recorded. The blood/plasma and urine samples, were collected for estimation of hemoglobin A1c, microalbuminuria, serum creatinine, urine creatinine, and routine urine analysis. ACR was calculated from urine creatinine and albumin while GFR was estimated by using a modification of diet in the renal disease equation. Results: Study recruited 1500 patients from 18 centers across India. The study population included 840 (56.05%) males. Mean age, body mass index and systolic blood pressure were 55.1 years, 27.4 kg/m 2 and 134.5 mmHg respectively. The mean duration of diabetes was 102.2 months. History of co-morbid diseases such as dyslipidemia, hypertension, microvascular complications and macrovascular complications was present in 657 (43.8%), 655 (43.7%), 268 (17.9%) and 104 (6.93%), respectively. This interim analysis revealed that about 46% of the T2DM patients had CKD (urinary albumin creatinine ratio (UACR) ≥30 mg/g and/or estimated GFR [eGFR] <60 mL/min/1.73 m 2 ). The renal dysfunction as per eGFR criteria (<60 mL/min/1.73 m 2 ) was reported in about 23% while as per UACR criteria (≥30 mg/g) it was reported in about 35% patients. Conclusion: This interim analysis results suggests that over 40% of T2DM patients have CKD. Despite this high number of T2DM patients with CKD, eGFR analysis shows there are almost 80% of T2DM patients still have reasonably good renal function (eGFR above 60 ml/min), which ensures less restrictions in selecting oral anti-diabetic drugs. Full study results from Start-India study will provide detail insights into the occurrence of CKD in patients with T2DM in India.http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=4;spage=520;epage=523;aulast=PrasannakumarAlbumin creatinine ratiochronic kidney diseasediabetes mellitusglomerular filtration raterenal dysfunction
collection DOAJ
language English
format Article
sources DOAJ
author M Prasannakumar
Rajesh Rajput
Krishna Seshadri
Pradeep Talwalkar
Pankaj Agarwal
G Gokulnath
Bhavesh Kotak
Ammar Raza
Hardik Vasnawala
Chirag Teli
spellingShingle M Prasannakumar
Rajesh Rajput
Krishna Seshadri
Pradeep Talwalkar
Pankaj Agarwal
G Gokulnath
Bhavesh Kotak
Ammar Raza
Hardik Vasnawala
Chirag Teli
An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)
Indian Journal of Endocrinology and Metabolism
Albumin creatinine ratio
chronic kidney disease
diabetes mellitus
glomerular filtration rate
renal dysfunction
author_facet M Prasannakumar
Rajesh Rajput
Krishna Seshadri
Pradeep Talwalkar
Pankaj Agarwal
G Gokulnath
Bhavesh Kotak
Ammar Raza
Hardik Vasnawala
Chirag Teli
author_sort M Prasannakumar
title An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)
title_short An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)
title_full An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)
title_fullStr An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)
title_full_unstemmed An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)
title_sort observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in india (start -india)
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Endocrinology and Metabolism
issn 2230-8210
2230-9500
publishDate 2015-01-01
description Objective: The primary objective of this study is to estimate the prevalence of chronic kidney disease (CKD) among type 2 diabetes mellitus (T2DM) patients in India. Materials and Methods: This cross-sectional, observational, epidemiological, multi-center, study is enrolling T2DM patients of either gender aged 30 years or above. This study aimed to enroll a total of 3000 T2DM patients at 30 participating hospitals/clinics across India and the data from a planned interim analysis of 1500 patients are presented here. The primary endpoint of the study is to estimate proportion of T2DM patients with CKD (glomerular filtration rate [GFR] <60 ml/min/1.73 m 2 or albumin creatinine ratio [ACR] ≥30 mg/g or ≥3 mg/mmol or both). Routine treatment, as administered by the treating physician, was continued without any study specific intervention. Patients′ data pertaining to demographic characteristics, medical history, current medication and physical examination were recorded. The blood/plasma and urine samples, were collected for estimation of hemoglobin A1c, microalbuminuria, serum creatinine, urine creatinine, and routine urine analysis. ACR was calculated from urine creatinine and albumin while GFR was estimated by using a modification of diet in the renal disease equation. Results: Study recruited 1500 patients from 18 centers across India. The study population included 840 (56.05%) males. Mean age, body mass index and systolic blood pressure were 55.1 years, 27.4 kg/m 2 and 134.5 mmHg respectively. The mean duration of diabetes was 102.2 months. History of co-morbid diseases such as dyslipidemia, hypertension, microvascular complications and macrovascular complications was present in 657 (43.8%), 655 (43.7%), 268 (17.9%) and 104 (6.93%), respectively. This interim analysis revealed that about 46% of the T2DM patients had CKD (urinary albumin creatinine ratio (UACR) ≥30 mg/g and/or estimated GFR [eGFR] <60 mL/min/1.73 m 2 ). The renal dysfunction as per eGFR criteria (<60 mL/min/1.73 m 2 ) was reported in about 23% while as per UACR criteria (≥30 mg/g) it was reported in about 35% patients. Conclusion: This interim analysis results suggests that over 40% of T2DM patients have CKD. Despite this high number of T2DM patients with CKD, eGFR analysis shows there are almost 80% of T2DM patients still have reasonably good renal function (eGFR above 60 ml/min), which ensures less restrictions in selecting oral anti-diabetic drugs. Full study results from Start-India study will provide detail insights into the occurrence of CKD in patients with T2DM in India.
topic Albumin creatinine ratio
chronic kidney disease
diabetes mellitus
glomerular filtration rate
renal dysfunction
url http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=4;spage=520;epage=523;aulast=Prasannakumar
work_keys_str_mv AT mprasannakumar anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT rajeshrajput anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT krishnaseshadri anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT pradeeptalwalkar anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT pankajagarwal anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT ggokulnath anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT bhaveshkotak anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT ammarraza anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT hardikvasnawala anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT chiragteli anobservationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT mprasannakumar observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT rajeshrajput observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT krishnaseshadri observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT pradeeptalwalkar observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT pankajagarwal observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT ggokulnath observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT bhaveshkotak observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT ammarraza observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT hardikvasnawala observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
AT chiragteli observationalcrosssectionalstudytoassesstheprevalenceofchronickidneydiseaseintype2diabetespatientsinindiastartindia
_version_ 1716773163961942016